GRAIL advances Galleri registrational clinical trial programme
GRAIL, Inc., a healthcare company whose mission is to detect cancer early when it can be cured, provided an update on the PATHFINDER 2 and NHS-Galleri registrational clinical trials evaluating the Galleri multi-cancer early detection (MCED) test. GRAIL has …